Establishing a Timeline to Discontinue Routine Testing of Asymptomatic Pregnant Women for Zika Virus Infection - American Samoa, 2016-2017.
The first patients with laboratory-confirmed cases of Zika virus disease in American Samoa had symptom onset in January 2016 (1). In response, the American Samoa Department of Health (ASDoH) implemented mosquito control measures (1), strategies to protect pregnant women (1), syndromic surveillance based on electronic health record (EHR) reports (1), Zika virus testing of persons with one or more signs or symptoms of Zika virus disease (fever, rash, arthralgia, or conjunctivitis) (1-3), and routine testing of all asymptomatic pregnant women in accordance with CDC guidance (2,3).All collected blood and urine specimens were shipped to the Hawaii Department of Health Laboratory for Zika virus testing and to CDC for confirmatory testing. Early in the response, collection and testing of specimens from pregnant women was prioritized over the collection from symptomatic nonpregnant patients because of limited testing and shipping capacity. The weekly numbers of suspected Zika virus disease cases declined from an average of six per week in January-February 2016 to one per week in May 2016. By August, the EHR-based syndromic surveillance (1) indicated a return to pre-outbreak levels. The last Zika virus disease case detected by real-time, reverse transcription-polymerase chain reaction (rRT-PCR) occurred in a patient who had symptom onset on June 19, 2016. In August 2016, ASDoH requested CDC support in assessing whether local transmission had been reduced or interrupted and in proposing a timeline for discontinuation of routine testing of asymptomatic pregnant women. An end date (October 15, 2016) was determined for active mosquito-borne transmission of Zika virus and a timeline was developed for discontinuation of routine screening of asymptomatic pregnant women in American Samoa (conception after December 10, 2016, with permissive testing for asymptomatic women who conceive through April 15, 2017).
W Thane
WT
Hancock
Heidi M
HM
Soeters
Susan L
SL
Hills
Ruth
R
Link-Gelles
Mary E
ME
Evans
W Randolph
WR
Daley
Emily
E
Piercefield
Magele Scott
MS
Anesi
Mary Aseta
MA
Mataia
Anaise M
AM
Uso
Benjamin
B
Sili
Aifili John
AJ
Tufa
Jacqueline
J
Solaita
Elizabeth
E
Irvin-Barnwell
Dana
D
Meaney-Delman
Jason
J
Wilken
Paul
P
Weidle
Karrie-Ann E
KE
Toews
William
W
Walker
Phillip M
PM
Talboy
William K
WK
Gallo
Nevin
N
Krishna
Rebecca L
RL
Laws
Megan R
MR
Reynolds
Alaya
A
Koneru
Carolyn V
CV
Gould
D018948:American Samoa / Q000453:epidemiology; D058070:Asymptomatic Diseases; D002487:Centers for Disease Control and Prevention, U.S.; D003955:Diagnostic Tests, Routine; D004196:Disease Outbreaks / Q000517:prevention & control*; D005260:Female; D006801:Humans; D011159:Population Surveillance / Q000379:methods*; D017410:Practice Guidelines as Topic; D011247:Pregnancy; D011251:Pregnancy Complications, Infectious / Q000453:epidemiology / Q000517:prevention & control*; D013997:Time Factors; D014481:United States; D000071244:Zika Virus / Q000302:isolation & purification; D000071243:Zika Virus Infection / Q000453:epidemiology / Q000517:prevention & control*